Article
Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of…
medRxiv: the preprint server for health sciences · 2021 · Olha Holubovska, author Denisa Bojkova, author Stefano Elli, author Marco Bechtel, author David Boltz, author Miguel Muzzio, author Xinjian Peng, author Frederico Sala, author Cesare Cosentino, author Alla Mironenko, author Jens Milde, author Yuriy Lebed, author Holger Stammer, author Andrew Goy, author Marco Guerrini, author Lutz Mueller, author Jindrich Cinatl, author Victor Margitich, author Aartjan J. W. te Velthuis, author
Key facts
| Title | Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial |
|---|---|
| First author | Olha Holubovska, author Denisa Bojkova, author Stefano Elli, author Marco Bechtel, author David Boltz, author Miguel Muzzio, author Xinjian Peng, author Frederico Sala, author Cesare Cosentino, author Alla Mironenko, author Jens Milde, author Yuriy Lebed, author Holger Stammer, author Andrew Goy, author Marco Guerrini, author Lutz Mueller, author Jindrich Cinatl, author Victor Margitich, author Aartjan J. W. te Velthuis, author |
| Journal | medRxiv : the preprint server for health sciences |
| Published | Jan 16, 2021 |
| DOI | 10.1101/2021.01.05.21249237 |
| Product codes mentioned | GDH, HRR, HTR, KDG |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1